Announcements Trials
Browse Landscape

Status

No longer available 1

Sponsor Class

OTHER 1

Study Type

Interventional 9Observational 3Expanded_access 1

Sponsor

Cancer Type

Endocrine 3NET 1Head & Neck 1CNS 1

Conditions

Glioblastoma 15Neuroblastoma 13Glioma 11Pheochromocytoma 7Neoplasms 6Recurrence 5Paraganglioma 5Pancreatic Neoplasms 3Melanoma 3Head and Neck Neoplasms 3Brain Neoplasms 3Stomach Neoplasms 2Ovarian Neoplasms 2Oligodendroglioma 2Neurofibroma, Plexiform 2Neuroectodermal Tumors, Primitive 2Medulloblastoma 2Diffuse Intrinsic Pontine Glioma 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Astrocytoma 2Wilms Tumor 1Urinary Bladder Neoplasms 1Typical Teratoid Rhabdoid Tumor 1Thyroid cancer, medullary 1Thyroid Neoplasms 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Rhabdoid Tumor 1

Interventions

fluorodopa F 18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Expanded_access × Carcinoid Tumor × CNS × Clear all
NCT02431715 2023-02-21

18F-FDOPA PET in Neuroendocrine Tumours

British Columbia Cancer Agency

No longer available
CNSEndocrineHead & Neck

Thyroid cancer, medullary, Carcinoid Tumor, Insulinoma, Neuroblastoma, Paraganglioma, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡